Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Feasibility study investigating CMR dobutamine stress testing before and after lung resection
We hypothesise that following lung resection,
In this study we aim to assess the feasibility of dobutamine stress cardiovascular magnetic resonance (CMR) scanning to assess RVCreserve pre- and post-operatively in patients undergoing lung resection.
Additionally, we hypothesise that one lung ventilation (with and without lung resection) is associated with biomarker evidence of RV injury.We will perform peri-operative cardiac biomarkers to differentiate between the contribution of major surgery (gastrectomy, lung resection and oesophagectomy), one lung ventilation (lung resection and oesophagectomy) and lung resection on RV injury.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Lung resection | 12 patients undergoing lobectomy. Pre and post-operative dobutamine stress CMR testing and cardiac biomarker testing. |
| |
| Oesophagectomy | 15 patients Peri-operative cardiac biomarker testing. |
| |
| Gastrectomy | 15 patients Peri-operative cardiac biomarker testing. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dobutamine stress CMR | Diagnostic Test | Dobutamine stress testing will be undertaken in keeping with local departmental clinical guidelines with a graded increase in dobutamine infusion up to a maximum of 10microgram/kg/min. The patients' medications will be managed in keeping with the usual clinical practice and departmental guidelines. At rest and on each graded level of dobutamine infusion we will collect cine loops of the cardiac cycle including a short-axis stack of the ventricles, a four-chamber view and flow imaging perpendicular to the main, left and right pulmonary arteries. Post-processing will be dual reported by blinded observers using the Argus analysis software (Siemens) according to a standardised protocol. A safety report of each CMR scan will be generated by a consultant cardiologist, any abnormalities identified will be referred to the appropriate medical speciality and highlighted to the patient's clinical team. |
| Measure | Description | Time Frame |
|---|---|---|
| 1) Feasibility of dobutamine stress CMR to measure RVCreserve following lung resection. | Reliability and variability will be assessed through dual reporting of the CMR images, testing intra-/inter-observer intraclass correlation coefficient (ICC) and coefficient of variation (CV). Study design will allow comparison to our previous resting studies published exercise literature and between pre- and post-operative imaging. | Pre-operative and 2 months post-operative |
| Measure | Description | Time Frame |
|---|---|---|
| 1) Acceptability of the dobutamine stress CMR protocol to patients, by questionnaire | Assessed by patient satisfaction questionnaires rate compared to our previous CMR studies that were performed without dobutamine stress testing. | Pre-operative and 2 months post-operative |
| 1) Acceptability of the dobutamine stress CMR protocol to patients, by completion |
Not provided
Inclusion Criteria:
1) Provision of informed consent 2) Age >16 years 3) Planned elective
Exclusion Criteria:
Pregnancy
On-going participation in any investigational research which could undermine the scientific basis of the study
Atrial fibrillation at baseline
Any contraindication to
a. CMR, i. Cardiac pacemaker, artificial heart valve, neurostimulator, cochlear implant ii. Aneurysm clips iii. Metal injuries to the eye iv. Loose metal in a part of the body b. Dobutamine stress testing as per the Society for Cardiovascular Magnetic Resonance64 i. Severe systemic arterial hypertension (≥220/120 mmHg) ii. Unstable angina pectoris iii. Severe aortic valve stenosis (peak aortic valve gradient >60mmHg or aortic valve area < 1cm2) iv. Complex cardiac arrhythmias including uncontrolled atrial fibrillation v. Hypertrophic obstructive cardiomyopathy vi. Myocarditis, endocarditis, or pericarditis vii. Uncontrolled heart failure
Lung resection specific
Wedge, segmental or sub-lobar lung resection
Pneumonectomy
Isolated right middle lobectomy
-
Not provided
Not provided
Not provided
Adult patients presenting for surgical resection of lung, oesophagus or stomach.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Adam Glass | Contact | +442890976378 | a.glass@qub.ac.uk | |
| Jon Silversides | Contact | j.silversides@qub.ac.uk |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Belfast Health and Social Care Trust | Recruiting | Belfast | Northern Ireland | BT12 6BA | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Serum samples frozen for batch analysis of cardiac biomarkers
|
| Cardiac biomarker sample | Diagnostic Test | blood samples will be collected pre-operatively, in recovery, on post-operative days 1 and 2, and at 4-8 weeks post-operatively |
|
Assessed by patient recruitment/withdrawal rate compared to our previous CMR studies that were performed without dobutamine stress testing. |
| Pre-operative and 2 months post-operative |
| 2) Incidence of complications related to dobutamine stress CMR | We will assess for the onset of any of the following during the scan
| Pre-operative and 2 months post-operative |
| 3) Change in RVCreserve change following lung resection | Comparison of the change in RVEF on stress pre- and post-operatively | Pre-operative and 2 months post-operative |
| 4) Change in PVreserve change following lung resection | Comparison of change in wave reflection on stress pre- and post-operatively | Pre-operative and 2 months post-operative |
| 5) Association between the changes in RVCreserve and markers of cardiac inflammation, BNP | Comparison of change in RVCreserve and the change in BNP | Pre-operative and 2 months post-operative |
| 5) Association between the changes in RVCreserve and markers of cardiac inflammation, hsTnT | Comparison of change in RVCreserve and the change in hsTnT. | Pre-operative and 2 months post-operative |
| 1) Post-operative change in BNP | Post-operative change in BNP in oesophagectomy compared to lung resection and gastrectomy. | Peri-operative blood samples, pre-op, immediately post-op, post-op days 1 and 2, 4-8 weeks post-op |
| D008171 |
| Lung Diseases |
| D012140 | Respiratory Tract Diseases |